← Back to Search

Stress and Symptom Management Program 2 for Neurofibromatosis

N/A
Waitlist Available
Led By Ana-Maria Vranceanu, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 weeks, 8 weeks, 6 months, 12 months
Awards & highlights

Summary

This trial will compare two different programs designed to help manage stress and symptoms in patients with neurofibromatosis. The goal is to see which program is more effective in improving quality of life and psychosocial functioning.

Eligible Conditions
  • Neurofibromatosis
  • Schwannomatosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 weeks, 8 weeks, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 weeks, 8 weeks, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Physical Quality of Life
Change in Psychological Quality of Life
Secondary study objectives
Anxiety
Coping Strategies
Depression
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Stress and Symptom Management Program 2Experimental Treatment1 Intervention
The Stress and Symptom Management Program 2 (SMP2) introduces and reinforces stress and symptom management skills. The program consists of 8 weekly sessions (90 minutes each), delivered through live videoconferencing.
Group II: Stress and Symptom Management Program 1Experimental Treatment1 Intervention
The Stress and Symptom Management Program 1 (SMP1) introduces and reinforces stress and symptom management skills. The program consists of 8 weekly sessions (90 minutes each), delivered through live videoconferencing.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,993 Previous Clinical Trials
13,230,497 Total Patients Enrolled
2 Trials studying Neurofibromatosis
151 Patients Enrolled for Neurofibromatosis
Ana-Maria Vranceanu, PhDPrincipal Investigator - Massachusetts General Hospital
Massachusetts General Hospital
20 Previous Clinical Trials
1,855 Total Patients Enrolled
2 Trials studying Neurofibromatosis
151 Patients Enrolled for Neurofibromatosis
~28 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top